You are here:

Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose.

Nielsen TB et al. Acta Oncol. 2013 Apr 29.

Nielsen TB, Hansen O, Schytte T, Brink C.
Acta Oncologica
Acta Oncol. 2013 Apr 29.
23627917

Link PubMed